---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-230749"
form_type: "8-K"
ticker: "DCOY"
cik: "0001615219"
company_name: "Decoy Therapeutics Inc."
filed_at: "2026-05-19T20:06:58+00:00"
generated_at: "2026-05-19T20:09:26.762673+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Decoy Therapeutics sets July 14, 2026 annual meeting; proposal deadline May 29

## Summary
- Annual meeting of stockholders scheduled for July 14, 2026; record date May 22, 2026.
- Deadline for Rule 14a-8 stockholder proposals is close of business on May 29, 2026.
- Deadline for director nominations and other Bylaw business: May 29, 2026.
- Universal proxy rule (Rule 14a-19) notices also due by May 29, 2026.

## SEC filing metadata
- accession: 0001193125-26-230749
- form_type: 8-K
- ticker: DCOY
- cik: 0001615219
- company_name: Decoy Therapeutics Inc.
- filed_at: 2026-05-19T20:06:58+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.08, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1615219/000119312526230749/0001193125-26-230749-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1615219/000119312526230749/dcoy-20260519.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-230749
- JSON: https://secwatch.observer/filing/0001193125-26-230749.json
- Plain text: https://secwatch.observer/filing/0001193125-26-230749.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.